The businessman accused of 90 fentanyl deaths would be a "VIP prisoner" in Marcos Paz prison

An Argentine businessman accused of causing the deaths of at least 90 people through contaminated fentanyl is reportedly being held under special conditions at the Marcos Paz federal prison, according to recent reports. Ariel García Furfaro, owner of pharmaceutical laboratories HLB Pharma and Ramallo, has been detained at the Complejo Penitenciario Federal II in Marcos Paz for nearly a year. His incarceration appears to offer him privileges typically reserved for high-profile detainees, allowing him to maintain a lifestyle distinct from that of ordinary inmates. García Furfaro is the main suspect in a criminal case involving the distribution of contaminated fentanyl that led to confirmed fatalities among patients. He is currently housed in Pabellón 6 of the prison, where he has access to a private cell and a high-end television set. Reports indicate that he engages in regular physical activity, reads extensively, and participates in weekly barbecues. Additionally, he maintains frequent contact with family members and business associates, including his brother Damián and his accountant, Diego Castrillón. These interactions allow him to oversee ongoing commercial ventures tied to his estate, such as the cable manufacturing company Epuyén SRL, real estate projects in General Rodríguez, and the construction of a bioproducts plant in Paraguay, which includes machinery imported from China. The situation within the prison has drawn attention from relatives of other inmates, who claim that a private truck has entered restricted areas of the facility to deliver food supplies for García Furfaro. The provisions come from a grocery store owned by his group, located in the Buenos Aires neighborhood of Flores. This arrangement suggests a level of logistical support that goes beyond standard prisoner accommodations. The case against García Furfaro is part of one of the most serious judicial investigations in recent years concerning public health. It has already led to the detention of officials from the National Administration of Medicines, Foods and Medical Technology (ANMAT). Recently, Nélida Bisio and Gabriela Mantecón Fumado were arrested but later released on bail of 150 million pesos. The investigation, led by Judge Ernesto Kreplak of La Plata, seeks to determine the responsibilities of García Furfaro’s laboratory in the production and distribution of the tainted fentanyl that caused numerous deaths. The case gained national prominence in 2025 when contaminated fentanyl vials linked to patient deaths were discovered in various hospitals. Patients died without apparent cause until tests revealed they had received doses from specific batches produced by García Furfaro's lab. As the forensic analysis progressed, the number of cases under review increased, with at least 90 confirmed deaths attributed to the tainted medication. However, there are suspicions that additional patients may have succumbed to the contamination without initial suspicion. The legal proceedings continue to unfold, with the potential for broader implications affecting even higher-level government figures, including Health Minister Mario Lugones. As the investigation unfolds, the unique circumstances of García Furfaro’s imprisonment remain a subject of scrutiny, highlighting the complex interplay between legal processes and the treatment of high-profile detainees within Argentina’s justice system.